Several drugs can cause secondary carnitine deficiency though OCTN2 inhibition including omeprazole [97], zwitterionic drugs (e.g., levofloxacin) [98], and anticancer drugs (e.g., etoposide, vinblastine, actinomycin D) [99]. This evidence concerns the gene SLC22A5 and systemic primary carnitine deficiency disease.